Mattias Ekstedt
Linköping University · 229 works · 17,657 citations · h-index 46
Top works
- Long‐term follow‐up of patients with NAFLD and elevated liver enzymes†‡
- Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
- Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
- Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
- Advancing the global public health agenda for NAFLD: a consensus statement
- Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting
- Changing epidemiology, global trends and implications for outcomes of NAFLD
- Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: A histopathological follow-up study
- 99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical
- Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long‐term follow‐up study
- The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease
- Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆
- Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis
- Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis
- The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?
- Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease
- A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe
- Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression
- Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis